Blood Transfusion Diagnostics Market Size Worth $ 8.44 Billion By 2034 | CAGR: 5.00%
The global blood transfusion diagnostics market size is expected to reach USD 8.44 billion by 2034, according to a new study by Polaris Market Research. The report “Blood Transfusion Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Reagents & Kits, Others); By Application; By End-Use; By Region; Segment Forecast, 2026 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising shift toward automation in blood banks is anticipated to aid blood collection facilities by reducing the time required to complete tests and addressing the workforce shortage needed to conduct essential tests. The implementation of automated systems is expected to help these facilities streamline their workflow and improve overall efficiency.
The proper handling and storage of blood and blood products is critical to blood transfusion diagnostics, as is the implementation of quality control methods. Blood is tested for microbial contamination on a regular basis, and it is thoroughly examined to ensure accurate labeling and documentation before it is approved for transfusion.
The global rise in chronic diseases such as cancer, sickle cell anemia, and thalassemia has resulted in an increase in blood transfusions, which has contributed to the market's growth. The demand for blood transfusion diagnostics has also increased as the number of traffic accidents, trauma cases, and blood transfusion procedures has increased.
Government initiatives and legislative measures mandating the use of blood transfusion diagnostics are critical to market growth. Particularly, regulations enacted by the United States Food and Drug Administration (FDA) require the use of Nucleic Acid Testing (NAT) to detect viral infections in donated blood. This critical step significantly reduces the risk of blood-borne disease transmission.
Automation and technological advancements in diagnostic testing methods, such as nucleic acid testing and immunoassays, have enhanced the accuracy and efficiency of blood screening. Similarly, there is a growing emphasis on improving the safety of blood transfusions by reducing the risk of transfusion-transmissible infections. The market has shifted toward molecular diagnostic techniques for the rapid and sensitive detection of pathogens. With an emphasis on blood safety, the blood transfusion diagnostics market is likely to continue evolving with innovations that simplify processes and improve the overall efficiency of blood testing and transfusion procedures.
Blood Transfusion Diagnostics Market Report Highlights
- North America held the largest market share of 38.0% in 2025. The presence of key companies and the rising adoption of healthcare technology boost the dominance.
- The U.S. dominated the regional market with 90.0% share in 2025. Increasing awareness of blood donation and growing demand for blood components fuel the leading position.
- The Asia Pacific market is expected to register the highest CAGR of 4.98% during the forecast period. Surging investments in healthcare infrastructure and the increasing adoption of innovative diagnostic technologies would fuel the regional market growth.
- The reagent & kits segment held the largest revenue share of 55.0% in 2025. The proliferation of donor screening reagents, typing, and a wide range of blood grouping, assays, and kits introduced by global and local entities drives the growth.
- The disease screening segment led the market with 56.0% share in 2025. The rising incidence of infectious diseases boosts the demand for disease screening.
- The global key market players include Abbott Laboratories, Bio-Rad Laboratories, Inc., Diamond Diagnostics, Diagnostica Stago, Electro Medical Technologies, F. Hoffman-La Roche Ltd., Grifols S.A., Immucor Inc., Ortho Clinical Diagnosis, Quotient Ltd.
Request a free sample copy or read the full market insights: Blood Transfusion Diagnostics Market
Polaris Market Research has segmented the Blood Transfusion Diagnostics market report based on product, application, end-use, and region:
Blood Transfusion Diagnostics, Product Outlook (Revenue - USD Billion, 2021 - 2034)
- Instrument
- Reagents & Kits
- Others
Blood Transfusion Diagnostics, Application Outlook (Revenue - USD Billion, 2021 - 2034)
- Blood Grouping
- Disease Screening
- Serological
- Molecular
Blood Transfusion Diagnostics, End-Use Outlook (Revenue - USD Billion, 2021 - 2034)
- Hospitals
- Blood Banks
- Diagnostic Laboratories
- Others
Blood Transfusion Diagnostics, Regional Outlook (Revenue - USD Billion, 2021 - 2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Blood Transfusion Diagnostics Market Report Scope
| Report Attributes | Details |
| Market size value in 2025 | USD 5.18 billion |
| Market size value in 2026 | USD 5.44 billion |
| Revenue forecast in 2034 | USD 8.44 billion |
| CAGR | 5.00% from 2026 – 2034 |
| Base year | 2025 |
| Historical data | 2021 – 2024 |
| Forecast period | 2026 – 2034 |
| Quantitative units | Revenue in USD billion and CAGR from 2026 to 2034 |
| Segments Covered | By Product, By Application, By End-Use, By Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Customization | Report customization as per your requirements with respect to countries, region, and segmentation |
| For Specific Research Requirements |
Source: Polaris Market Research Analysis
